The application of fluorescence lifetime readouts in high-throughput screening

被引:13
作者
Moger, Julian
Gribbon, Philip
Sewing, Andreas
Winlove, C. Peter
机构
[1] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England
[2] Pfizer Global Res & Dev, Sandwich Labs, Sandwich, Kent, England
关键词
high-throughput screening; fluorescence lifetime; FIDA; fluorescence polarization;
D O I
10.1177/1087057106291541
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Measurement of fluorescence lifetime is a well-established technique, which has recently been introduced into the portfolio of assay formats used in high-throughput screening (HTS). This investigation establishes appropriate conditions for using lifetime measurements to reduce the impact of compound interference effects during large-scale HTS of corporate screening files. Experimental data on mixtures of standard fluorophores and interfering compounds (from 5 HTS campaigns) have been combined with a theoretical model to identify the minimum data quality required, defined by the photon count in the peak channel, for discrimination of biological activity. Single-component fluorophore lifetimes can be recovered with an error of 1%, with a peak photon count of 10(2), but the same accuracy with a 2-component decay requires a peak photon count of 10(3). When a 3rd component is introduced, the minimum peak count increases to 10(4). The influence of scattered light on lifetime determination was investigated using an emulsion (diameters 25-675 nm). The measured decays of interfering compounds, identified as autofluorescent, show that the vast majority have a very short lifetime that can readily be resolved from the reporter fluorophore, using appropriate data-fitting methods.
引用
收藏
页码:765 / 772
页数:8
相关论文
共 15 条
  • [1] STANDARDIZATION OF INTRALIPID FOR LIGHT-SCATTERING IN CLINICAL PHOTODYNAMIC THERAPY
    ALLARDICE, JT
    ABULAFI, AM
    WEBB, DG
    WILLIAMS, NS
    [J]. LASERS IN MEDICAL SCIENCE, 1992, 7 (04) : 461 - 465
  • [2] An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases
    Fowler, A
    Swift, D
    Longman, E
    Acornley, A
    Hemsley, P
    Murray, D
    Unitt, J
    Dale, I
    Sullivan, E
    Coldwell, M
    [J]. ANALYTICAL BIOCHEMISTRY, 2002, 308 (02) : 223 - 231
  • [3] Fluorescence readouts in HTS: no gain without pain?
    Gribbon, P
    Sewing, A
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (22) : 1035 - 1043
  • [4] Single-molecule detection technologies in miniaturized high-throughput screening:: Fluorescence intensity distribution analysis
    Haupts, U
    Rüdiger, M
    Ashman, S
    Turconi, S
    Bingham, R
    Wharton, C
    Hutchinson, J
    Carey, C
    Moore, KJ
    Pope, AJ
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (01) : 19 - 33
  • [5] Screening scheme based on measurement of fluorescence lifetime in the nanosecond domain
    Hoefelschweiger, BK
    Pfeifer, L
    Wolfbeis, OS
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (07) : 687 - 694
  • [6] Two-dimensional fluorescence intensity distribution analysis:: Theory and applications
    Kask, P
    Palo, K
    Fay, N
    Brand, L
    Mets, Ü
    Ullmann, D
    Jungmann, J
    Pschorr, J
    Gall, K
    [J]. BIOPHYSICAL JOURNAL, 2000, 78 (04) : 1703 - 1713
  • [7] A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
    McGovern, SL
    Caselli, E
    Grigorieff, N
    Shoichet, BK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1712 - 1722
  • [8] MCGOVERN SL, 2002, J MED CHEM, V45, P4265
  • [9] Ohmi N, 2000, J BIOMOL SCREEN, V5, P463
  • [10] Homogeneous proximity tyrosine kinase assays: Scintillation proximity assay versus homogeneous time-resolved fluorescence
    Park, YW
    Cummings, RT
    Wu, L
    Zheng, S
    Cameron, PM
    Woods, A
    Zaller, DM
    Marcy, AI
    Hermes, JD
    [J]. ANALYTICAL BIOCHEMISTRY, 1999, 269 (01) : 94 - 104